Association of sclerostin with cardiovascular events and mortality in dialysis patients

INTRODUCTION: Sclerostin has been reported to be a novel biomarker associated with the bone-vascular axis. In this study, we determined the relationships between serum sclerostin and all-cause mortality, the prevalence of cardiovascular events (CVEs), and coronary artery calcifications (CACs) in dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Yun, Yang, Min, Wang, Jiao, Cui, Li, Jiang, Zhenxing, Ding, Jiule, Li, Min, Zhou, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170300/
https://www.ncbi.nlm.nih.gov/pubmed/32216514
http://dx.doi.org/10.1080/0886022X.2020.1741386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170300/
https://www.ncbi.nlm.nih.gov/pubmed/32216514
http://dx.doi.org/10.1080/0886022X.2020.1741386

Ejemplares similares